CWP
IART icon

CFM Wealth Partners’s Integra LifeSciences IART Stock Holding History

CFM Wealth Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16
Closed -$1K – 291
2020
Q2 		$1K Sell
16
-77
-83% -$3.79K ﹤0.01% 487
2020
Q1 		$4K Sell
93
-51
-35% -$2.68K ﹤0.01% 484
2019
Q4 		$9K Buy
+144
New +$8.57K ﹤0.01% 427

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

CFM Wealth Partners's IART Position: Q3 2020 in Review

CFM Wealth Partners sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 16 shares — an estimated $1K sold.

CFM Wealth Partners first reported a position in IART in Q4 2019 and held it in 3 quarters. The position peaked at $9K in Q4 2019. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

  • CFM Wealth Partners reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
  • CFM Wealth Partners sold 16 Integra LifeSciences shares in Q3 2020, an estimated $1K.
  • CFM Wealth Partners first reported a position in Integra LifeSciences in Q4 2019 and held it in 3 quarters.
  • CFM Wealth Partners's Integra LifeSciences position peaked at $9K in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on CFM Wealth Partners's 13F filing for Q3 2020, filed 10 Nov 2020.